Hong Kong: Shanghai HeartCare to price HK$1.13bn IPO at top of range

Shanghai HeartCare Medical Technology, a medical devices maker, is to price an IPO of up to HK$1.13bn (US$150m) at the maximum per share of HK$171, the upper end of the HK$160 – HK$171 per share marketing range. Pricing is expected to be announced on August 19. Most of the proceeds will be allocated to core…